Anoikis resistance constitutes a critical pathophysiological mechanism driving metastatic progression in colorectal cancer. While in vitro models are essential for mechanistic studies, conventional 2D cultures inadequately replicate tumor microenvironment (TME) complexity. In this study, we developed a biomimetic composite hydrogel (GHP4a) composed of 4-arm-PEGDA, Gelatin Methacryloyl, and Hyaluronic acid Methacryloyl to establish compact 3D cell spheres that mimic TME. The GHP4a demonstrates superior biocompatibility, suitable mechanical strength at 600-700 Pa, and biomimetic properties that promote cell proliferation and differentiation when co-culturing Caco-2 cells. The cell anchorage and survival for anoikis resistance are enhanced compared to traditional 2D cell incubation due to a well-organized 3D formation akin to the extracellular matrix (ECM). The biomimetic mechanism may be attributed to the fact that the GHP4a promoted the activation of key pro-survival pathways, including FAK and PI3K/Akt signaling, and suppressed caspase-mediated apoptosis. Single-cell RNA sequencing revealed distinct transcriptional profiles within the proliferating T cell population, suggesting a novel regulatory mechanism of T cell-mediated anti-tumor immunity in the TME. Additionally, radiomic analysis identified significant differences in tumor heterogeneity and texture between GHP4a-based 3D cultures and traditional 2D models. These findings established the GHP4a as an effective candidate for the in vitro tumor anoikis resistance model, providing a unique approach for studying anoikis resistance in colorectal cancer and offering a robust tool for the development of advancing cancer diagnosis and therapy strategies.
High‐throughput screening (HTS) can be used when ab initio information is unavailable for rational design of new materials, generating data on properties such as chemistry and topography that control cell behavior. Biomaterial screens are typically fabricated as microarrays or “chips,” seeded with the cell type of interest, then phenotyped using immunocytochemistry and high‐content imaging, generating vast quantities of image data. Typically, analysis is only performed on fluorescent cell images as it is relatively simple to automate through intensity thresholding of cellular features. Automated analysis of bright‐field images is rarely performed as it presents an automation challenge as segmentation thresholds that work in all images cannot be defined. This limits the biological insight as cell response cannot be correlated to specifics of the biomaterial feature (e.g., shape, size) as these features are not visible on fluorescence images. Computer Vision aims to digitize tasks humans do by sight, such as identify objects by their shape. Herein, two case studies demonstrate how open‐source approaches, (region‐based convolutional neural network and algorithmic [OpenCV]), can be integrated into cell‐biomaterial HTS analysis to automate bright‐field segmentation across thousands of images, allowing rapid, spatial definition of biomaterial features during cell analysis for the first time.
Background: To investigate the risk factors for myocardial infarction, recurrent in-stent restenosis (ISR) and target vessel revascularization (TVR) in patients with coronary ISR within 4 years after revascularization. Methods: A total of 1884 patients who were hospitalized at Fuwai Hospital for ISR and successfully treated with coronary intervention between January 2017 and December 2018 were included to determine whether there were myocardial infarction, recurrent ISR, TVR and other major adverse cardiovascular events (MACEs) within 4 years after intervention. The patients were divided into the MACE group (215 patients) and the non-MACE group (1669 patients). The clinical data of patients in the two groups were compared, and the risk factors for postoperative MACEs in the ISR patients were obtained by multivariate logistic regression analysis. The receiver operating characteristic (ROC) curve was used to determine the optimal prediction threshold for postoperative MACEs in ISR patients. The difference in survival curves between the two groups was compared using Kaplan‒Meier survival analysis. Results: The albumin (43.42 ± 4.77 vs. 44.17 ± 4.46, p = 0.021), direct bilirubin (2.5 (2, 3.5) vs. 2.8 (2.07, 3.73), p = 0.036) and free triiodothyronine (FT3) (2.85 ± 0.43 vs. 2.92 ± 0.42, p = 0.019) levels in the MACE group were significantly lower than those in the non-MACE group, and there was a significant negative correlation between albumin and FT3 and MACEs. The results of univariate and multivariate logistic regression analyses revealed that FT3 was an independent predictor of postoperative MACEs in ISR patients (Odds Ratio (OR) = 0.626, 95% CI: 0.429–0.913, p = 0.015). The ROC curve analysis determined that an FT3 value of 2.785 pmol/L was the optimal prediction threshold. According to the threshold, ISR patients were divided into the FT3 <2.785 group and the FT3 ≥2.785 group. The Kaplan‒Meier analysis revealed that the postoperative recurrence rate of MACEs of the FT3 <2.785 group was substantially greater than that of the FT3 ≥2.785 group (Hazard Ratio (HR) = 0.76, 95% CI: 0.58–0.994, p = 0.044). Conclusions: FT3 can be used as an independent predictor of postoperative myocardial infarction, recurrent ISR and TVR in ISR patients. When FT3 is <2.785 pmol/L, the incidence of postoperative myocardial infarction, recurrent ISR and TVR in ISR patients increases significantly.
11 August 2025 in Artificial Intelligence in Health
Over the past decade, the global increase in cancer prevalence and cancer-related mortality has fueled extensive research to enhance the effectiveness of cancer treatments. Such efforts include the fabrication of lab-grown tissues and organs for transplantation, and the development of in vitro models for cancer drug testing and screening. Notably, three-dimensional (3D) tissue models offer advantages over two-dimensional cultures and have benefited from recent advancements in cutting-edge techniques like 3D printing, enabling the reconstruction of various tumor models in vitro. In this review, we focus on recent progress in in vitro 3D tumor models, with particular emphasis on the roles of 3D bioprinting and artificial intelligence. Furthermore, we provide future perspectives on employing bioprinting to develop tumor models that accurately mimic the complexity and heterogeneity of real tumor microenvironments.
Poly(glycerol monomethacrylate)-block-poly(2-hydroxypropyl methacrylate) (PGMA-PHPMA) with worm-like morphology is a typical example of reversible addition–fragmentation chain transfer (RAFT) dispersion polymerized thermo-responsive copolymer via polymerization-induced self-assembly (PISA) in aqueous solution. Chain transfer agents (CTAs) are the key component in controlling RAFT, the structures of which determine the end functional groups of the polymer chain. It is therefore of interest to monofunctionalize the polymers via CTA moiety, for bioactive functionality conjugation and in the meantime maintain the precisely controlled morphology of the copolymers and the related property. In this work, a newly designed CTA 5-(2-(tert-butoxycarbonylamino) ethylamino)-2-cyano-5-oxopentan-2-yl benzodithioate (t-Boc CPDB) was synthesized and used for the RAFT polymerization of PGMA45-PHPMA120. Subsequently, PGMA45-PHPMA120 copolymers with primary amine, maleimide, and reduced L-glutathione (a tripeptide) monofunctionalized terminals were synthesized via deprotection and conjugation reactions. These monofunctionalized copolymers maintain worm-like morphology and thermo-responsive property in aqueous solution (10% w/v), as confirmed by the transmission electron microscopy (TEM) images, and the observation of the phase transition behavior in between 4 °C and room temperature (~20 °C), respectively. Summarily, a range of thermo-responsive monofunctionalized PGMA45-PHPMA120 diblock copolymer worms were successfully synthesized, which are expected to offer potential biomedical applications, such as in polymer therapeutics, drug delivery, and diagnostics.
10 September 2024 in Cell Reports Physical Science